Company Update

• As previously advised to the ASX on 17th December 2025, the initial report on Anatara’s Anti- Obesity Project pre-clinical studies concluded that a candidate compound, referred to as “AOC”, had 2 independent measures suggesting activity of statistical significance in assisting the management of weight reduction. • The Mechanism of Action (MOA) assays have been completed on the pre-clinical studi